Last updated on June 2019

Non-Interventional Study on the Tolerability and Efficacy of IVIG

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Any patient who needs to be treated with a product of this class because of his/her medical condition and whom the treating physician decides to prescribe Octagam or panzyga regularly, may be included.

Exclusion Criteria:

  • None

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.